US Stock MarketDetailed Quotes
IONS Ionis Pharmaceuticals
- 35.900
- +0.530+1.50%
Close Nov 27 16:00 ET
- 35.900
- 0.0000.00%
Post 17:07 ET
5.67BMarket Cap-14713P/E (TTM)
36.410High35.000Low977.19KVolume35.400Open35.370Pre Close35.12MTurnover0.62%Turnover RatioLossP/E (Static)157.90MShares54.44552wk High8.56P/B5.62BFloat Cap33.33052wk Low--Dividend TTM156.65MShs Float86.582Historical High--Div YieldTTM3.99%Amplitude2.500Historical Low35.944Avg Price1Lot Size
Ionis Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -7.21%133.81M | 19.55%225.25M | -8.45%119.5M | 34.10%787.65M | 113.65%324.51M | -9.74%144.21M | 40.82%188.41M | -8.03%130.52M | -27.53%587.37M | -65.48%151.89M |
| Operating revenue | -7.21%133.81M | 19.55%225.25M | -8.45%119.5M | 34.10%787.65M | 113.65%324.51M | -9.74%144.21M | 40.82%188.41M | -8.03%130.52M | -27.53%587.37M | -65.48%151.89M |
| Cost of revenue | -51.12%1.07M | 64.13%4.16M | 60.16%2.15M | -35.30%9.13M | -16.93%3.06M | 44.62%2.19M | -46.53%2.54M | -67.79%1.34M | 30.20%14.12M | 65.59%3.69M |
| Gross profit | -6.53%132.74M | 18.94%221.09M | -9.16%117.35M | 35.81%778.51M | 116.89%321.44M | -10.26%142.02M | 44.04%185.87M | -6.22%129.18M | -28.31%573.25M | -66.15%148.2M |
| Operating expense | -1.39%281.36M | 4.02%287.18M | 9.67%266.86M | 15.13%1.13B | -8.03%327.56M | 31.25%285.33M | 28.67%276.07M | 24.62%243.33M | 20.76%983.45M | 63.25%356.17M |
| Selling and administrative expenses | -12.00%61.6M | 41.11%65.11M | 15.66%52.64M | 54.76%232.6M | 48.23%71M | 103.49%70M | 36.51%46.14M | 33.37%45.52M | -12.05%150.3M | 24.09%47.9M |
| -General and administrative expense | -12.00%61.6M | ---- | 15.66%52.64M | 54.76%232.6M | 48.23%71M | 103.49%70M | ---- | 33.37%45.52M | -12.05%150.3M | 24.09%47.9M |
| Research and development costs | 2.06%219.76M | -3.42%222.06M | 8.29%214.22M | 7.98%899.63M | -16.78%256.56M | 17.67%215.33M | 27.20%229.93M | 22.77%197.81M | 29.48%833.15M | 71.67%308.27M |
| Operating profit | -3.70%-148.62M | 26.72%-66.09M | -30.98%-149.51M | 13.77%-353.71M | 97.06%-6.11M | -142.34%-143.31M | -5.48%-90.2M | -98.50%-114.15M | -2,683.07%-410.2M | -194.70%-207.97M |
| Net non-operating interest income expense | -3.43%-22.73M | -14.24%-22.79M | -29.12%-22.11M | -906.14%-81.5M | -1,220.53%-22.45M | -946.62%-21.98M | -849.81%-19.95M | -706.93%-17.12M | 12.90%-8.1M | 22.73%-1.7M |
| Non-operating interest income | ---- | ---- | --49K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Non-operating interest expense | 4.19%21.23M | 14.24%22.79M | 29.93%20.56M | 2,599.89%75.6M | 5,112.25%20.85M | 2,447.38%20.38M | 2,393.25%19.95M | 1,824.94%15.82M | -36.36%2.8M | -50.00%400K |
| Total other finance cost | -6.25%1.5M | ---- | 23.08%1.6M | 11.32%5.9M | 23.08%1.6M | 23.08%1.6M | ---- | 0.00%1.3M | 8.16%5.3M | -7.14%1.3M |
| Other net income (expense) | 11.50%27.25M | -30.64%22.68M | 57.65%28.9M | -36.87%101.22M | -84.43%25.76M | 67.57%24.44M | 314.65%32.69M | 512.33%18.33M | 3,298.24%160.33M | 2,091.28%165.42M |
| Gain on sale of security | 23.26%27.11M | 2.58%22.07M | 58.13%28.62M | -48.11%86.97M | -84.61%25.36M | 122.79%21.99M | 833.13%21.51M | 490.72%18.1M | 731.90%167.6M | 2,245.16%164.77M |
| Other non- operating income (expenses) | -94.20%142K | -94.55%610K | 20.43%277K | 295.99%14.26M | -38.52%399K | -48.08%2.45M | 190.94%11.18M | 22.99%230K | 25.47%-7.27M | 236.06%649K |
| Income before tax | -2.34%-144.1M | 14.52%-66.2M | -26.37%-142.73M | -29.45%-333.97M | 93.76%-2.77M | -201.46%-140.81M | 24.72%-77.45M | -76.28%-112.94M | -785.09%-257.99M | -119.71%-44.33M |
| Income tax | -154.85%-3.62M | -99.18%64K | -99.34%75K | 175.38%32.32M | -19.80%6.5M | 2,232.86%6.6M | 246.99%7.84M | 940.22%11.38M | 2,230.13%11.74M | 2,573.27%8.1M |
| Net income | 4.70%-140.48M | 22.31%-66.27M | -14.86%-142.8M | -35.80%-366.29M | 82.33%-9.26M | -213.69%-147.41M | 18.88%-85.29M | -90.78%-124.32M | -843.18%-269.72M | -123.34%-52.43M |
| Net income continuous Operations | 4.70%-140.48M | 22.31%-66.27M | -14.86%-142.8M | -35.80%-366.29M | 82.33%-9.26M | -213.69%-147.41M | 18.88%-85.29M | -90.78%-124.32M | -843.18%-269.72M | -123.34%-52.43M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 4.70%-140.48M | 22.31%-66.27M | -14.86%-142.8M | -35.80%-366.29M | 82.33%-9.26M | -213.69%-147.41M | 18.88%-85.29M | -90.78%-124.32M | -843.18%-269.72M | -123.34%-52.43M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 4.70%-140.48M | 22.31%-66.27M | -14.86%-142.8M | -35.80%-366.29M | 82.33%-9.26M | -213.69%-147.41M | 18.88%-85.29M | -90.78%-124.32M | -843.18%-269.72M | -123.34%-52.43M |
| Basic earnings per share | 7.77%-0.95 | 25.00%-0.45 | -12.64%-0.98 | -34.74%-2.56 | 83.78%-0.06 | -212.12%-1.03 | 18.92%-0.6 | -89.13%-0.87 | -850.00%-1.9 | -123.27%-0.37 |
| Diluted earnings per share | 7.77%-0.95 | 25.00%-0.45 | -12.64%-0.98 | -34.74%-2.56 | 83.78%-0.06 | -212.12%-1.03 | 18.92%-0.6 | -89.13%-0.87 | -850.00%-1.9 | -126.24%-0.37 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data